The epididymis and accessory sex organs

2010 ◽  
pp. 90-103 ◽  
Author(s):  
Terry T. Turner
Keyword(s):  
1989 ◽  
Vol 123 (1) ◽  
pp. 83-91 ◽  
Author(s):  
K.-L. Kolho ◽  
I. Huhtaniemi

ABSTRACT The acute and long-term effects of pituitary-testis suppression with a gonadotrophin-releasing hormone (GnRH) agonist, d-Ser(But)6des-Gly10-GnRH N-ethylamide (buserelin; 0·02, 0·1, 1·0 or 10 mg/kg body weight per day s.c.) or antagonist, N-Ac-d-Nal(2)1,d-p-Cl-Phe2,d-Trp3,d-hArg(Et2)6,d-Ala10-GnRH (RS 68439; 2 mg/kg body weight per day s.c.) were studied in male rats treated on days 1–15 of life. The animals were killed on day 16 (acute effects) or as adults (130–160 days; long-term effects). Acutely, the lowest dose of the agonist decreased pituitary FSH content and testicular LH receptors, but with increasing doses pituitary and serum LH concentrations, intratesticular testosterone content and weights of testes were also suppressed (P< 0·05–0·01). No decrease was found in serum FSH or in weights of accessory sex organs even with the highest dose of the agonist, the latter finding indicating continuing secretion of androgens. The GnRH antagonist treatment suppressed pituitary LH and FSH contents and serum LH (P< 0·05–0·01) but, as with the agonist, serum FSH remained unaltered. Testicular testosterone and testis weights were decreased (P <0·01) but testicular LH receptors remained unchanged. Moreover, the seminal vesicle and ventral prostate weights were reduced, in contrast to the effects of the agonists. Pituitary LH and FSH contents had recovered in all adult rats treated neonatally with agonist and there was no effect on serum LH and testosterone concentrations or on fertility. In contrast, in adult rats treated neonatally with antagonist, weights of testis and accessory sex organs remained decreased (P <0·01–0·05) but hormone secretion from the pituitary and testis had returned to normal except that serum FSH was increased by 80% (P <0·01). Interestingly, 90% of the antagonist-treated animals were infertile. It is concluded that treatment with a GnRH agonist during the neonatal period does not have a chronic effect on pituitary-gonadal function. In contrast, GnRH antagonist treatment neonatally permanently inhibits the development of the testis and accessory sex organs and results in infertility. Interestingly, despite the decline of pituitary FSH neonatally, neither of the GnRH analogues was able to suppress serum FSH values and this differs from the concomitant changes in LH and from the effects of similar treatments in adult rats. Journal of Endocrinology (1989) 123, 83–91


Endocrinology ◽  
1981 ◽  
Vol 109 (3) ◽  
pp. 837-843 ◽  
Author(s):  
ANGELO MARIOTTI ◽  
MARK THORNTON ◽  
MICHAEL MAWHINNEY
Keyword(s):  

Endocrinology ◽  
1964 ◽  
Vol 74 (4) ◽  
pp. 635-642 ◽  
Author(s):  
CHARLES D. KOCHAKIAN ◽  
JOHN HILL ◽  
DAVID G. HARRISON

1985 ◽  
Vol 23 (1) ◽  
pp. 39-49 ◽  
Author(s):  
William J. Hendry ◽  
Barbara C. Eller ◽  
Marie-Claire Orgebin-Crist ◽  
Benjamin J. Danzo

1985 ◽  
Vol 110 (4) ◽  
pp. 572-576 ◽  
Author(s):  
G. Schleicher ◽  
W. E. Stumpf ◽  
K.-U. Thiedemann ◽  
U. Drews

Abstract. Male, female and Tfm mice (testicular feminization) were injected with [3H]oestradiol or [3H]dihydrotestosterone, and autoradiograms prepared of male accessory sex organs and of the cervico-vaginal portion of the female reproductive tract. After injection of [3H]oestradiol in male, female and Tfm animals a nuclear concentration of radioactivity was found in a subpopulation – about 20–30% – of the neurons of the genital ganglion. No such concentration was seen after [3H]dihydrotestosterone. The results suggest a direct genomic effect of oestradiol on certain neurons of the autonomic genital ganglion in both sexes.


1982 ◽  
Vol 45 ◽  
pp. 85-88 ◽  
Author(s):  
J A Thomas ◽  
K A Curto ◽  
M J Thomas

Sign in / Sign up

Export Citation Format

Share Document